Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00242918 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | completed | Phase 2 | 29 | Benaroya Research InstituteOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00147680 | Uterine Papillary Serous Cancer (UPSC) Trial | completed | Phase 2 | 30 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00607607 | A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer | completed | Phase 2 | 44 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00020696 | Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 4 | Jan 10, 2012 | clinicaltrials |
| NCT00116779 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 127 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 19, 2011 | clinicaltrials |
| NCT00569257 | Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors | completed | Phase 2 | 85 | AEterna ZentarisINDUSTRY | 2 | Dec 13, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Nov 3, 2011 | clinicaltrials |
| NCT00005857 | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036075 | Study Using CP-461 to Treat Advanced Prostate Cancer | completed | Phase 2 | 25 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00466986 | Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer | completed | Phase 2 | 40 | Southeastern Gynecologic OncologyOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00429559 | Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma | completed | Phase 1 / Phase 2 | 31 | Hellenic Oncology Research GroupOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00286793 | Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC | completed | Phase 1 / Phase 2 | 76 | Ascenta TherapeuticsINDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00593580 | Bone Health in Gynecologic Cancers-does FOSAVANCE Help?(FOSAVANCE) | completed | Phase 2 | 60 | British Columbia Cancer AgencyOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00148772 | Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | completed | Phase 2 | 29 | Endeavor HealthOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00050596 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00004177 | Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00134654 | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 16, 2011 | clinicaltrials |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 86 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 16, 2011 | clinicaltrials |
| NCT00268593 | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer | completed | Phase 2 | 48 | Progen PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00069888 | A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy | completed | Phase 2 | 83 | SanofiINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00117949 | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 | completed | Phase 2 | 82 | Ferring PharmaceuticalsINDUSTRY | 1 | May 23, 2011 | clinicaltrials |
| NCT00750386 | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas | completed | Phase 1 / Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00554086 | Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.(CHICS) | completed | Phase 2 | 65 | Canadian Urology Research ConsortiumOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 90 | Groupe D'Etude des Tumeurs Uro-GenitalesOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00193271 | Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer | completed | Phase 2 | 30 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00004083 | Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003297 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer | completed | Phase 1 / Phase 2 | 50 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00468286 | Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 2 | 133 | Ferring PharmaceuticalsINDUSTRY | 5 | Mar 23, 2011 | clinicaltrials |
| NCT00716794 | A Phase I/II Study of HE3235 in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 64 | Harbor TherapeuticsINDUSTRY | 1 | Mar 9, 2011 | clinicaltrials |
| NCT00054522 | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy | completed | Phase 2 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00189566 | Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse | completed | Phase 2 | 165 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00517621 | Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire | completed | Phase 2 | 100 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00844506 | p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer(ISA-P53-CTX) | completed | Phase 2 | 19 | University Medical Center GroningenOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00316407 | Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Swedish Medical CenterOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT00319787 | Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer | completed | Phase 2 | 102 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00637871 | Casodex - Nolvadex Combination | completed | Phase 2 | — | AstraZenecaINDUSTRY | 0 | Jan 24, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT00252941 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 20 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00340184 | A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients | completed | Phase 2 | 55 | Korean Gynecologic Oncology GroupOTHER | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 1 | Oct 4, 2010 | clinicaltrials |
| NCT00002508 | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00217529 | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217555 | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Feb 7, 2012source: clinicaltrials